p16INK4a is a Useful Marker of Human Papillomavirus Integration Allowing Risk Stratification for Cervical Malignancies |
Cheah, Phaik-Leng
(Department of Pathology, Faculty of Medicine, University of Malaya)
Looi, Lai-Meng (Department of Pathology, Faculty of Medicine, University of Malaya) Teoh, Kean-Hooi (Department of Pathology, Faculty of Medicine, University of Malaya) Mun, Kein-Seong (Department of Pathology, Faculty of Medicine, University of Malaya) Nazarina, Abdul Rahman (Department of Pathology, Faculty of Medicine, University of Malaya) |
1 | Benevolo M, Mottolese M, Marandino F, et al (2006). Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol, 19, 384-91. DOI |
2 | Bergeron C, Ordi J, Schmidt D, et al (2010). Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol, 133, 395-406. DOI |
3 | Cheah PL, Looi LM, Sivanesaratnam V (2011). Human papillomavirus in cervical cancers of Malaysians. J Obstet Gynaecol Res, 37, 489-95 DOI |
4 | Cheah PL, Looi LM, Mun KS, Nazarina AR, Teoh KH (2011). Implications of continued upregulation of p16INK4a through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix. Malaysian J Pathol, 33, 83-7. |
5 | Doorbar J (2005). The papillomavirus life cycle. J Clin Virol, 32, 7-15 |
6 | Eleuterio J Jr, Giraldo PC, Goncalves AK, et al (2007). Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus. Acta Obstet Gynecol Scand, 86, 94-8. DOI |
7 | Klaes R, Friedrich T, Spitkovsky D, et al (2001). Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer, 92, 276-84. DOI ScienceOn |
8 | Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA (2007). p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol, 31, 33-43 DOI |
9 | Kurshumliu F, Thorns C, Gashi-Luci L (2009). p16INK4A in routine practice as a marker of cervical epithelial neoplasia. Gynecol Oncol, 115, 127-31 DOI |
10 | Lesnikova I, Lidang M, Hamilton-Dutoit S, Koch J (2009). p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens. Diagn Pathol, 4, 22-?. DOI |
11 | Lim GCC, Rampal S, Halimah Y (Eds) (2008). Cancer Incidence in Peninsular Malaysia 2003-2005. The Third Report of the National Cancer Registry. National Cancer Registry, Ministry of Health Malaysia. Kuala Lumpur. |
12 | Missaoui N, Trabelsi A, Hmissa S, et al (2010). p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women. Pathol Res Pract, 206, 550-5 DOI |
13 | Murphy N, Ring M, Heffron CC, et al (2005). p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol, 58, 525-34 DOI |
14 | Nishino HT, Tambouret RH, Wilbur DC (2011). Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology. Cancer Cytopathol, 119, 219-27 DOI |
15 | Reuschenbach M, Vinokurova S, von Knebel Doeberitz M (2011). HPV-associated carcinomas of the female genital tract : Molecular mechanisms of development. Pathologe, 32, 451-60. DOI |
16 | Rodríguez AC, Schiffman M, Herrero R, et al (2008). Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst, 100, 513-7 DOI |
17 | Schiffman M, Wentzensen N, Wacholder S, et al (2011). Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst, 103, 368-83 DOI |
18 | Sherr CJ, Roberts JM (2004). Living with or without cyclins and cyclin-dependent kinases. Genes Dev, 18, 2699-711 DOI ScienceOn |
19 | Stanley M (2010). Pathology and epidemiology of HPV infection in females. Gynecol Oncol, 117, 5-10 DOI ScienceOn |
20 | Syrjanen K (2011). Persistent high-risk human papillomavirus (HPV) infections as surrogate endpoints of progressive cervical disease. Potential new endpoint for efficacy studies with new-generation (non-HPV 16/18) prophylactic HPV vaccines. Eur J Gynaecol Oncol, 32, 17-33 |
21 | Ukpo OC, Flanagan JJ, Ma XJ, et al (2011). High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol, 35, 1343-50. DOI |
22 | Van Niekerk D, Guillaud M, Matisic J, et al (2007). p16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing. Gynecol Oncol, 107, 233-40 DOI |
23 | Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9 DOI ScienceOn |
![]() |